Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen

Authors:

Abstract
5-Methoxypsoralen (5-MOP) (Psoraderm 5) tablets obtained from France and 5-MOP micronized in capsule (manufactured in this pharmacy department) were administered to 7 psoriasis patients in a 1.2 mg/kg body wt dose schedule. Bioavailability and phototoxicity were compared. The maximum serum concentration and the area under the concentration curve were significantly higher (P < 0.01) after administration of the capsules, indicating higher bioavailability. No erythema developed in any of the patients after administration of the tablets, whereas with the capsules 4 of the patients developed erythema at the test site. The absence of erythema following the use of the tablets is probably due to the poor bioavailability of this preparation.

This publication has 6 references indexed in Scilit: